Literature DB >> 19690986

Nicotinic receptors, amyloid-beta, and synaptic failure in Alzheimer's disease.

Sofia Jürgensen1, Sergio T Ferreira.   

Abstract

Dysfunctional cholinergic transmission is thought to underlie, at least in part, memory impairment and cognitive deficits in Alzheimer's disease (AD). However, it is still unclear whether this is a consequence of the loss of cholinergic neurons and elimination of nicotinic acetycholine receptors (nAChRs) in AD brain or of a direct impact of molecular interactions of the amyloid-beta (Abeta) peptide with nAChRs, leading to dysregulation of receptor function. This review examines recent progress in our understanding of the roles of nicotinic receptors in mechanisms of synaptic plasticity, molecular interactions of Abeta with nAChRs, and how Abeta-induced dysregulation of nicotinic receptor function may underlie synaptic failure in AD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19690986     DOI: 10.1007/s12031-009-9237-0

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  91 in total

1.  Amyloid beta oligomers induce impairment of neuronal insulin receptors.

Authors:  Wei-Qin Zhao; Fernanda G De Felice; Sara Fernandez; Hui Chen; Mary P Lambert; Michael J Quon; Grant A Krafft; William L Klein
Journal:  FASEB J       Date:  2007-08-24       Impact factor: 5.191

2.  beta-Amyloid(1-42) peptide directly modulates nicotinic receptors in the rat hippocampal slice.

Authors:  D L Pettit; Z Shao; J L Yakel
Journal:  J Neurosci       Date:  2001-01-01       Impact factor: 6.167

3.  Selective loss of central cholinergic neurons in Alzheimer's disease.

Authors:  P Davies; A J Maloney
Journal:  Lancet       Date:  1976-12-25       Impact factor: 79.321

4.  Identification of sequence motifs that target neuronal nicotinic receptors to dendrites and axons.

Authors:  Jian Xu; Yongling Zhu; Stephen F Heinemann
Journal:  J Neurosci       Date:  2006-09-20       Impact factor: 6.167

5.  Nicotinic receptor-mediated enhancement of long-term potentiation involves activation of metabotropic glutamate receptors and ryanodine-sensitive calcium stores in the dentate gyrus.

Authors:  Philip Welsby; Michael Rowan; Roger Anwyl
Journal:  Eur J Neurosci       Date:  2006-12       Impact factor: 3.386

Review 6.  Acetylcholinesterase inhibitors as disease-modifying therapies for Alzheimer's disease.

Authors:  D Muñoz-Torrero
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

Review 7.  Cholinergic treatments with emphasis on m1 muscarinic agonists as potential disease-modifying agents for Alzheimer's disease.

Authors:  Abraham Fisher
Journal:  Neurotherapeutics       Date:  2008-07       Impact factor: 7.620

8.  Epibatidine induces long-term potentiation (LTP) via activation of alpha4beta2 nicotinic acetylcholine receptors (nAChRs) in vivo in the intact mouse dentate gyrus: both alpha7 and alpha4beta2 nAChRs essential to nicotinic LTP.

Authors:  Shogo Matsuyama; Akira Matsumoto
Journal:  J Pharmacol Sci       Date:  2003-10       Impact factor: 3.337

9.  Characterization of muscarinic receptor subtypes in Alzheimer and control brain cortices by selective muscarinic antagonists.

Authors:  A L Svensson; I Alafuzoff; A Nordberg
Journal:  Brain Res       Date:  1992-11-20       Impact factor: 3.252

Review 10.  Mammalian nicotinic acetylcholine receptors: from structure to function.

Authors:  Edson X Albuquerque; Edna F R Pereira; Manickavasagom Alkondon; Scott W Rogers
Journal:  Physiol Rev       Date:  2009-01       Impact factor: 37.312

View more
  22 in total

1.  Galanthamine plus estradiol treatment enhances cognitive performance in aged ovariectomized rats.

Authors:  R B Gibbs; A M Chipman; R Hammond; D Nelson
Journal:  Horm Behav       Date:  2011-08-26       Impact factor: 3.587

2.  Crystal structure of a human neuronal nAChR extracellular domain in pentameric assembly: Ligand-bound α2 homopentamer.

Authors:  Nikolaos Kouvatsos; Petros Giastas; Dafni Chroni-Tzartou; Cornelia Poulopoulou; Socrates J Tzartos
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-04       Impact factor: 11.205

3.  Amyloid-β depresses excitatory cholinergic synaptic transmission in Drosophila.

Authors:  Liqun Fang; Jingjing Duan; Dongzhi Ran; Zihao Fan; Ying Yan; Naya Huang; Huaiyu Gu; Yulan Zhu
Journal:  Neurosci Bull       Date:  2012-10-03       Impact factor: 5.203

Review 4.  Amyloid-β as a modulator of synaptic plasticity.

Authors:  Mordhwaj S Parihar; Gregory J Brewer
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

Review 5.  Naturally-expressed nicotinic acetylcholine receptor subtypes.

Authors:  Jie Wu; Ronald J Lukas
Journal:  Biochem Pharmacol       Date:  2011-07-20       Impact factor: 5.858

Review 6.  Synaptotoxic Signaling by Amyloid Beta Oligomers in Alzheimer's Disease Through Prion Protein and mGluR5.

Authors:  A Harrison Brody; Stephen M Strittmatter
Journal:  Adv Pharmacol       Date:  2017-10-25

7.  Co-activation of selective nicotinic acetylcholine receptors is required to reverse beta amyloid-induced Ca2+ hyperexcitation.

Authors:  Julianna L Sun; Sarah A Stokoe; Jessica P Roberts; Matheus F Sathler; Kaila A Nip; Jiayi Shou; Kaitlyn Ko; Susan Tsunoda; Seonil Kim
Journal:  Neurobiol Aging       Date:  2019-09-19       Impact factor: 4.673

Review 8.  The nicotinic acetylcholine receptor: smoking and Alzheimer's disease revisited.

Authors:  Mona Mehta; Abdu Adem; Maninder S Kahlon; Marwan N Sabbagh
Journal:  Front Biosci (Elite Ed)       Date:  2012-01-01

9.  A large scale multivariate parallel ICA method reveals novel imaging-genetic relationships for Alzheimer's disease in the ADNI cohort.

Authors:  Shashwath A Meda; Balaji Narayanan; Jingyu Liu; Nora I Perrone-Bizzozero; Michael C Stevens; Vince D Calhoun; David C Glahn; Li Shen; Shannon L Risacher; Andrew J Saykin; Godfrey D Pearlson
Journal:  Neuroimage       Date:  2012-01-08       Impact factor: 6.556

10.  Beta Amyloid Differently Modulate Nicotinic and Muscarinic Receptor Subtypes which Stimulate in vitro and in vivo the Release of Glycine in the Rat Hippocampus.

Authors:  Stefania Zappettini; Massimo Grilli; Guendalina Olivero; Elisa Mura; Stefania Preda; Stefano Govoni; Alessia Salamone; Mario Marchi
Journal:  Front Pharmacol       Date:  2012-07-27       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.